The Great Publishing Debate
Join top researchers as they go head to head and debate two of academic publishing most contentious topics.
Event Details
Date: Tuesday 30 June
Time: 12:00pm – 1:00pm
Register now to secure your spot
Discussion A: Open Access Publishing is the only way to go!
For the affirmative discussing that open access publishing should be used, Prof. Rik Thompson from QUT
For the negative discussing that open access publishing should not be used, Prof. Josephine Forbes from Mater Research.
Discussion B: All Journals should adopt 'open' peer review
For the affirmative discussing that all journals should adopt an open peer review, Selena Bartlett from QUT .
For the negative discussing that journals should not adopt open peer review Andrew Brooks from UQDI.
Join in, as you can have your say in this interactive seminar! Register now to attend.
Following on from the highly attended ‘Which Journal and Why?’ seminar in May, ‘The Great Publishing Debate’ is the second of a four part seminar series focusing on Academic Publishing.
After hearing first hand experiences from authors and editors of the widely used publishing processes the second seminar will focus on the rising idea of implementing open peer reviews. Would open peer reviews create transparency or would reviewers be reluctant to criticize work especially if the researcher holds a senior position? Join us and let’s discuss it together.
| Speaker | Bio |
|
Professor Rik Thompson Associate Director IHBI QUT and Professor in Breast Cancer Research |
Professor Thompson gained his PhD and completed postdoctoral training at NIH, USA and the Lombardi Cancer Research Center, Georgetown University Medical Center, USA. Before returning to Australia he established a breast cancer invasion and metastasis laboratory in Georgetown. Professor Thompson returned to St. Vincent's Institute, Melbourne as a group leader for invasion and merastasis in the Victorian Breast Cancer Research Consortium and stayed until 2014 when he joined IHBI QUT as a Professor in Breast Cancer Research and Theme leader for 'Chronic Disease and Aging. In 2016 Professor Thompson took up the role of Associate Director at IHBI, based at TRI. Professor Thompson has served on various grant review panels, serves on a number of editorial boards including Clinical and Experimental Metastasis, The Breast Journal and Cancer Microenvironment, and is Associate Editor (Epithelial Plasticity) for Cells Tissues Organs. He has 151 peer-reviewed primary publications and 51 reviews, book chapters and editorials - many in breast cancer. |
|
Professor Josephine Forbes Program Leader of the Chronic Disease Biology and Care research theme at Mater and a NHMRC Senior Research Fellow |
Professor Forbes specialises in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research, which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme. Her work to date has resulted in more than 160 publications in highly ranked journals which have been cited > 9000 times. Her primary research focuses on the pathological mechanisms that contribute to diabetes and its complications including advanced glycation and mitochondrial energy production. This is with a view to designing and translating therapies to combat these diseases. She has received numerous awards for her research including the Commonwealth Health Minister’s Award for Excellence in Medical Research in Australia and a Young Researcher Award from the International Diabetes Federation. |
|
Professor Selena Bartlett Group Leader, Addiction Neuroscience and Obesity QUT |
Professor Selena Bartlett is a Group Leader in Neuroscience and Obesity at the TRI at the Institute of Health and Biomedical Innovation and a Research Capacity Building Professor in the School of Clinical Sciences, Faculty of Health, QUT. Dr Bartlett is the CEO and Founder of MiGFiT Inc, a QUT Bluebox start-up spun out her research lab that is focussed on retraining mindset for emotional eating fitness. The biggest problem in diets that fail. She won the Outstanding Achievement Award and the Biotech Research Award and was an Ambassador for the Women in Technology organization. |
|
Dr Andrew Brooks Group Leader of the Cytokine Receptor Signalling Group at UQDI |
Dr Brooks completed his PhD on Dengue virus at James Cook University, before moving to the St Jude Children’s Research Hospital in Memphis, TN, USA where he researched the role of Epstein - Barr virus in B-cell lymphomagenesis. His research in the early years of his career formed the foundation for his interest in the links between viruses and cancer and lead to his move back to Queensland in 2006 to join the research group headed by Emeritus Professor Michael Waters at The University of Queensland. His research has led to publications in journals including Science, Nature Cell Biology, Blood, PNAS, and Oncogene with over 1000 citations (Web of Knowledge or over 1500 Google Scholar) with an h-index of 16 (Web of Knowledge) or 19 (Google Scholar; i10-index 20).. He has been the recipient of over $4.3 million in research grant funding (over $1.6 million as CIA/primary investigator) and has a number of national and international collaborations. Outside of the lab, Andrew is an editorial board member for the Journal Cancers and Review, editor for Molecular and Structural Endocrinology for the Journal Frontiers in Endocrinology and has also been a committee member of the Australian Early-Mid Career Researchers Forum (AEMCRF). |
